CAS 1133819-87-0

MSDC 0602

CAS : 1133819-87-0

Formule : C₁₉H₁₇NO₅S

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 371.4070

Ref: IN-DA00IMP7

5-(4-(2-(3-Methoxyphenyl)-2-Oxoethoxy)Benzyl)Thiazolidine-2,4-Dione

CAS : 1133819-87-0

5-(4-(2-(3-Methoxyphenyl)-2-Oxoethoxy)Benzyl)Thiazolidine-2,4-Dione

Degré de pureté : 98+%

Masse moléculaire : 371.41g/mol

Ref: 54-OR1023852

Azemiglitazone

CAS : 1133819-87-0

Azemiglitazone

Degré de pureté : ≥95%

Masse moléculaire : 371.41g/mol

Ref: 54-BUP13273

Azemiglitazone

CAS : 1133819-87-0

Azemiglitazone (MSDC 0602) is an insulin sensitizer potentially for the treatment of diabetes.

Formule : C₁₉H₁₇NO₅S

Degré de pureté : 98.29% - 99.6%

Couleur et forme : Solid

Masse moléculaire : 371.41

Ref: TM-T4639

MSDC 0602

Produit contrôlé

CAS : 1133819-87-0

Formule : C₁₉H₁₇NO₅S

Couleur et forme : Neat

Masse moléculaire : 371.41

Ref: TR-M755420

MSDC-0602

CAS : 1133819-87-0

MSDC-0602 is a novel antidiabetic drug that has been shown to inhibit the uptake of glucose by adipose tissues. This drug also stimulates mitochondrial function and increases the capacity of human liver cells to metabolize fatty acids. MSDC-0602 is currently in clinical trials for use in patients with hepatic steatosis, diabetes, or cancer. It is hoped that this drug will be effective against these diseases due to its ability to increase the uptake of glucose by liver cells and adipose tissues and its stimulation of mitochondrial function.

Formule : C₁₉H₁₇NO₅S

Degré de pureté : Min. 95%

Masse moléculaire : 371.41 g/mol

Ref: 3D-IVB81987